Sept 9 (Reuters) - Prometic Life Sciences Inc PLI.TO :
* PROMETIC REPORTS FIRST SUBJECT DOSED IN PHASE I CLINICAL STUDY WITH SINGLE ASCENDING DOSES OF PBI-4547
Sept 9 (Reuters) - Prometic Life Sciences Inc PLI.TO :
* PROMETIC REPORTS FIRST SUBJECT DOSED IN PHASE I CLINICAL STUDY WITH SINGLE ASCENDING DOSES OF PBI-4547